Celiac disease develops through a multi-step process where genetic susceptibility, an immune system misfire, and environmental triggers converge to make the body attack its own small intestine in response to gluten. It affects roughly 0.7% to 2.9% of the general population worldwide, is more common in females, and can appear at any age. Understanding how this process unfolds helps explain why some people with the right genetics never develop the disease while others do.
It Starts With Specific Genes
Celiac disease requires a particular genetic setup. Nearly all people with celiac carry one of two gene variants that code for specific immune system proteins on the surface of their cells. These proteins act like docking stations that present fragments of food to immune cells for inspection. In people with celiac, these docking stations happen to grip gluten fragments especially well, which sets the stage for the immune reaction that follows.
About 25% of the general Caucasian population carries these gene variants. Yet only a small fraction of them ever develop celiac disease. That gap between genetic risk and actual disease is the central puzzle, and it tells you that genes are necessary but not sufficient. Something else has to go wrong.
Gluten Breaks Through the Gut Barrier
Under normal conditions, the cells lining your small intestine are locked together by structures called tight junctions, which prevent large protein fragments from slipping through. Gluten is unusually difficult to digest. Human digestive enzymes can’t fully break it down, leaving behind long, sturdy peptide chains. In most people, those chains stay on the inside surface of the gut and pass through harmlessly.
In genetically susceptible individuals, gluten triggers the release of a protein called zonulin. Zonulin loosens those tight junctions, opening gaps between intestinal cells. This allows partially digested gluten fragments to cross the gut lining and reach the tissue underneath, called the lamina propria, where the immune system is active. Research published in Gastroenterology showed that gliadin (a component of gluten) binds to a specific receptor on intestinal cells, triggering this zonulin release and increasing intestinal permeability. This “leaky gut” step is considered one of the earliest events in celiac disease development.
An Enzyme Modifies Gluten Into Something Worse
Once gluten fragments reach the tissue beneath the gut lining, they encounter an enzyme that the body normally uses for tissue repair. This enzyme chemically modifies specific spots on the gluten fragments, converting certain amino acids into a slightly different form. The modification is small at the molecular level, but the consequences are large: the altered gluten fragments now fit much more snugly into those genetically determined docking stations on immune cells.
This is where genetics and biochemistry intersect. The enzyme reshapes gluten into a form that the immune system of genetically susceptible people is primed to recognize as dangerous. In people without the relevant gene variants, the modified gluten doesn’t fit the docking stations nearly as well, and the immune system largely ignores it. Interestingly, this same enzyme becomes a target of the immune response itself. The body produces antibodies against it, which is why testing for these antibodies is one of the most reliable ways to detect celiac disease, with sensitivity and specificity both around 98%.
The Immune System Launches a Full Attack
Once the modified gluten fragments are loaded onto those docking stations, they’re presented to a type of immune cell that orchestrates adaptive immune responses. These cells recognize the gluten as a threat and activate, releasing signaling molecules that amplify inflammation. Studies of intestinal tissue from celiac patients show that this activation produces several inflammatory signals, including ones that recruit and energize other immune cells.
One of those signals is particularly destructive. It activates killer cells that are already stationed within the lining of the small intestine. Normally, these cells patrol quietly, but the inflammatory signal essentially reprograms them into aggressive attackers. They begin destroying the cells that line the intestinal villi, the tiny finger-like projections that absorb nutrients from food. Over time, this ongoing destruction flattens the villi, a process called villous atrophy. With fewer and shorter villi, the intestine loses surface area for nutrient absorption, leading to the malnutrition, diarrhea, bloating, and fatigue that characterize celiac disease.
This is not a one-time event. Every time a person with active celiac disease eats gluten, the cycle restarts: barrier breach, enzyme modification, immune activation, tissue destruction. The damage is cumulative and continues as long as gluten remains in the diet.
Viral Infections May Flip the Switch
Since most people with the relevant genes never develop celiac, researchers have looked for the environmental triggers that push a susceptible person from tolerance to immune activation. Viral infections, particularly those affecting the gut, are one of the strongest candidates.
A birth cohort study published in Frontiers in Immunology found that enterovirus infections were significantly more common in children who went on to develop celiac disease compared to matched controls. Children who later developed celiac had six times the odds of prior enterovirus infections before celiac-related antibodies appeared. Rotavirus, adenovirus, reovirus, and parechovirus have all been linked to celiac onset in various studies. The proposed mechanism is straightforward: a viral infection in the gut creates an inflammatory environment at the same time gluten is present, and immune cells that would normally learn to tolerate gluten instead learn to attack it.
Viral infections early in life may also cause lasting changes in the gut’s microbial community, creating a second pathway to disease.
Gut Bacteria Shift Before Symptoms Appear
A longitudinal study published in PNAS tracked the gut microbiomes of children at genetic risk for celiac disease and found distinct microbial shifts occurring months before the disease became clinically apparent. In the months leading up to celiac onset, children who developed the disease showed increases in bacterial species previously linked to autoimmune and inflammatory conditions. At the same time, bacteria known for anti-inflammatory effects declined.
These changes weren’t subtle. Pro-inflammatory species increased at multiple time points in the 15 months before disease onset, while protective species dropped. Shifts in how gut bacteria process the amino acid tryptophan also appeared, along with changes in at least one protist species and one viral species. Whether these microbial changes help cause celiac or simply reflect the early stages of immune disruption isn’t fully settled, but they appear to be part of the disease’s developmental timeline rather than a consequence of it.
When Gluten Is Introduced Doesn’t Change the Risk
For years, parents of at-risk children were told that introducing gluten at just the right time might prevent celiac disease. Randomized controlled trials have since shown this isn’t the case. A position paper from the European Society for Paediatric Gastroenterology, Hepatology, and Nutrition reviewed the evidence and concluded that introducing gluten anywhere between 4 and 12 months of age does not change a child’s overall risk of developing celiac disease during childhood.
Earlier introduction does lead to earlier disease appearance in high-risk children, but it doesn’t increase the total number who eventually develop it. Later introduction delays onset but doesn’t prevent it. The cumulative incidence remains the same. This finding reinforced that celiac disease cannot currently be prevented through dietary timing alone, pointing back to the complex interplay of genetics, immune programming, infections, and microbial environment as the true drivers.
Why It Can Appear at Any Age
Celiac disease is often thought of as a childhood condition, but it can develop for the first time in adults who have eaten gluten without problems for decades. This makes sense given what we know about the trigger mechanisms. A gut infection at age 45, a shift in gut bacteria after a course of antibiotics, or physiological stress from surgery or pregnancy could all, in theory, disrupt the balance that previously kept the immune system tolerant of gluten. The genetic susceptibility was always there. What changed was the environment.
This also explains why celiac clusters in families. First-degree relatives of someone with celiac disease carry substantially higher risk, not only because they share genes but often because they share microbial environments, dietary patterns, and early-life exposures. The disease doesn’t follow a simple inherited pattern like eye color. It follows a threshold model, where enough risk factors have to accumulate before the immune system tips from tolerance into attack.